NovoCure Ltd (NVCR)
16.50
+0.36
(+2.26%)
USD |
NASDAQ |
May 10, 16:00
16.50
0.00 (0.00%)
After-Hours: 20:00
NovoCure Cash and Short Term Investments (Quarterly): 870.15M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 870.15M |
| December 31, 2023 | 910.62M |
| September 30, 2023 | 921.25M |
| June 30, 2023 | 940.82M |
| March 31, 2023 | 958.04M |
| December 31, 2022 | 969.42M |
| September 30, 2022 | 970.32M |
| June 30, 2022 | 948.52M |
| March 31, 2022 | 932.30M |
| December 31, 2021 | 937.70M |
| September 30, 2021 | 933.78M |
| June 30, 2021 | 899.03M |
| March 31, 2021 | 864.40M |
| December 31, 2020 | 842.58M |
| September 30, 2020 | 234.46M |
| June 30, 2020 | 346.71M |
| March 31, 2020 | 331.27M |
| December 31, 2019 | 326.09M |
| September 30, 2019 | 312.60M |
| Date | Value |
|---|---|
| June 30, 2019 | 284.58M |
| March 31, 2019 | 256.60M |
| December 31, 2018 | 245.88M |
| September 30, 2018 | 227.70M |
| June 30, 2018 | 218.96M |
| March 31, 2018 | 216.32M |
| December 31, 2017 | 183.31M |
| September 30, 2017 | 186.56M |
| June 30, 2017 | 184.38M |
| March 31, 2017 | 189.25M |
| December 31, 2016 | 219.63M |
| September 30, 2016 | 235.55M |
| June 30, 2016 | 200.85M |
| March 31, 2016 | 235.77M |
| December 31, 2015 | 269.42M |
| September 30, 2015 | 137.32M |
| June 30, 2015 | 163.50M |
| December 31, 2014 | 102.61M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
234.46M
Minimum
Sep 2020
970.32M
Maximum
Sep 2022
736.73M
Average
904.82M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| AtriCure Inc | 105.96M |
| NeuroMetrix Inc | 18.00M |
| Repligen Corp | 780.62M |
| Teleflex Inc | 237.42M |
| Perspective Therapeutics Inc | 9.238M |